Francis Chris bought WVE
February 26, 2026 · Form 4 insider transaction
Francis Chris bought 17,900 shares of Wave Life Sciences, Inc. at $3.87 per share, a transaction worth $69.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
17,900
Price
$3.87
Total value
$69.3K
InsiderFrancis Chris
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after79,767
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.